Author
Listed:
- Janeth Vásquez-Granda
- Jessy C. Tarrillo-Olivos
- Naomy R. Pereyra-Urbina
- Jhanina Paola P- Santa-Cruz
- Yajahira M. Cabanillas-Carrero
- Víctor Álvarez-Manrique
- Liset Z. Sairitupa-Sanchez
- Wilter C. Morales-García
Abstract
Objective: This study aims to conduct a brief literature review on post-COVID-19 complications in obese patients. Design: A literature review based on a narrative synthesis. Data Sources: The databases consulted include Science Direct, Scopus, Scielo, Google Scholar, and PubMed. Study Selection: Multiple articles were selected, applying inclusion criteria focused on post-COVID-19 complications in obese patients, with publications ranging from 2020 to 2024. Irrelevant studies were excluded. The final selection included articles from 10 different countries. Data Extraction: From each study, key data were extracted, including research design, population characteristics, and main reported complications. The information was organized narratively to facilitate comparison of findings across studies. Results: Out of 261,357 articles, 15 relevant articles were selected for the review. These articles were published in 10 countries, as follows: Spain (3 middle-income and 1 lower-middle income), Italy (1 lower-middle income, 1 high-income, and 1 mixed-income), India (2 middle and lower income), Russia (1 middle income), Japan (1 high, middle, and low income), Germany (1 middle income), United States (1 middle income), Mexico (1 middle income), Brazil (1 middle income), and China (1 high and middle income). The findings indicate that socioeconomic inequalities tend to increase the risk of COVID-19-related mortality. Conclusion: COVID-19 is associated with type 2 diabetes, an increased risk of coronary problems, hypertension, and nerve damage such as polyneuropathy, affecting muscle strength and increasing the mortality rate in respiratory diseases such as COPD, leading to lung damage and fibrosis. Treatment should be comprehensive, including vaccines, respiratory exercises, and physiotherapy, where the drug Veklury (remdesivir) has shown efficacy in accelerating recovery and strengthening the immune system. Additionally, post-COVID conditions such as anxiety, depression, and persistent respiratory issues should be addressed.
Suggested Citation
Handle:
RePEc:dbk:sicomu:2025v3a34
DOI: 10.62486/sic2025185
Download full text from publisher
To our knowledge, this item is not available for
download. To find whether it is available, there are three
options:
1. Check below whether another version of this item is available online.
2. Check on the provider's
web page
whether it is in fact available.
3. Perform a
for a similarly titled item that would be
available.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:dbk:sicomu:2025v3a34. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Javier Gonzalez-Argote (email available below). General contact details of provider: https://sic.ageditor.org/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.